Shanghai Imstat Medical Technology

Shanghai Imstat Medical Technology is a specialized contract research organization (CRO) based in Shanghai, China, that provides clinical data management and statistical analysis services for the biopharmaceutical industry. The company is particularly recognized for its expertise in vaccine clinical trials, having supported numerous phase I, II, and III studies for infectious disease preventatives, including COVID-19, pertussis, tetanus, and diphtheria vaccines. Imstat works closely with major vaccine developers like CanSino Biologics to ensure the accuracy and integrity of clinical data through advanced biostatistical modeling and regulatory-compliant data curation. Its contributions are frequently cited in high-impact medical journals, reflecting its role as a key technical partner in the development of novel immunization products.